Why Eli Lilly and Company (LLY) is Skyrocketing? - Yahoo Finance
Yesterday • Google News
Eli Lilly and Company (LLY)
US$ 839.9614.3%
Price Chart
Key Statistics
Market Cap
$ 754.27B
P/E Ratio
71.91
Revenue (TTM)
$ 45.04B
Volume
10.53M
52W High
$ 969.25
52W Low
$ 677.09
Dividend Yield
0.71%
Beta
0.50
Technicals
50-Day MA
835.6604
200-Day MA
847.1837
52 Week High
969.2515
52 Week Low
677.0912
About LLY
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, H.
Employees
47000
Headquarters
Indianapolis, IN
CEO
Mr. David A. Ricks
Latest News
Biggest stock movers Thursday: TSM, LLY, UNH, and more (TSM:NYSE) - Seeking Alpha
Yesterday • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
32.36
Percentile: 70.22
Environmental Risk Score
0.63
Percentile: 1
Social Risk Score
16.68
Percentile: 1
Governance Risk Score
13.31
Percentile: 1
Controversy Level
ESG data provided by Sustainalytics, Inc.
LLY
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg